Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children
Clinical trial NCT01014091 · TERMINATED
Trial details
- NCT number
- NCT01014091
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-01-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.